These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15082669)

  • 21. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical dysplasia in HIV infected women in Maiduguri, Nigeria.
    Chama CM; Nggada H; Gashau W
    J Obstet Gynaecol; 2005 Apr; 25(3):286-8. PubMed ID: 16147738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
    Miziara ID; Weber R
    Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection.
    Ormaasen V; Bruun JN; Sandvik L; Holberg-Petersen M; Gaarder PI
    Scand J Infect Dis; 2003; 35(6-7):383-8. PubMed ID: 12953949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART).
    Ampel NM
    Semin Respir Infect; 2001 Dec; 16(4):257-62. PubMed ID: 11740827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.
    Silverberg MJ; Ahdieh L; Munoz A; Anastos K; Burk RD; Cu-Uvin S; Duerr A; Greenblatt RM; Klein RS; Massad S; Minkoff H; Muderspach L; Palefsky J; Piessens E; Schuman P; Watts H; Shah KV
    Sex Transm Dis; 2002 Aug; 29(8):427-35. PubMed ID: 12172526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
    Fife KH; Wu JW; Squires KE; Watts DH; Andersen JW; Brown DR
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):274-82. PubMed ID: 19387354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexually transmitted infections and cervicovaginal dysplasia in a cohort of human immunodeficiency virus-positive women in Turin.
    Pugliese A; Saini A; Andronico L; Pagliano G; Gallo G
    Cancer Detect Prev; 2001; 25(1):32-9. PubMed ID: 11270419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervico-vaginal dysplasia--papillomavirus-induced and HIV-1 infection: role of correlated markers for prognostic evaluation.
    Pugliese A; Andronico L; Gennero L; Pagliano G; Gallo G; Torre D
    Cell Biochem Funct; 2002 Sep; 20(3):233-6. PubMed ID: 12125100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia.
    Gedle D; Kumera G; Eshete T; Ketema K; Adugna H; Feyera F
    J Health Popul Nutr; 2017 May; 36(1):15. PubMed ID: 28506307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections.
    Hawes SE; Critchlow CW; Faye Niang MA; Diouf MB; Diop A; Touré P; Aziz Kasse A; Dembele B; Salif Sow P; Coll-Seck AM; Kuypers JM; Kiviat NB
    J Infect Dis; 2003 Aug; 188(4):555-63. PubMed ID: 12898443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
    J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
    Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
    Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.